226 related articles for article (PubMed ID: 12142073)
21. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.
Lujambio A; Portela A; Liz J; Melo SA; Rossi S; Spizzo R; Croce CM; Calin GA; Esteller M
Oncogene; 2010 Dec; 29(48):6390-401. PubMed ID: 20802525
[TBL] [Abstract][Full Text] [Related]
22. The role of DNA hypermethylation in human neoplasia.
Toyota M; Issa JP
Electrophoresis; 2000 Jan; 21(2):329-33. PubMed ID: 10675010
[TBL] [Abstract][Full Text] [Related]
23. Predicting aberrant CpG island methylation.
Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12253-8. PubMed ID: 14519846
[TBL] [Abstract][Full Text] [Related]
24. [Methylation status of IEX-1 gene promotor CpG island in malignant hematopoietic cell lines].
Li XY; Shen JZ; Shen SF; Fu HY; Zhou HR; Wu DS; Zhang YY; Zheng YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):473-6. PubMed ID: 21518511
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic changes in solid and hematopoietic tumors.
Toyota M; Issa JP
Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation and gene silencing in cancer: which is the guilty party?
Clark SJ; Melki J
Oncogene; 2002 Aug; 21(35):5380-7. PubMed ID: 12154400
[TBL] [Abstract][Full Text] [Related]
27. Promoter hypermethylation of multiple genes in astrocytic gliomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
[TBL] [Abstract][Full Text] [Related]
28. Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer.
Soozangar N; Sadeghi MR; Jeddi F; Somi MH; Shirmohamadi M; Samadi N
J Cell Physiol; 2018 May; 233(5):3968-3981. PubMed ID: 28888056
[TBL] [Abstract][Full Text] [Related]
29. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF
Oncogene; 2002 Jun; 21(27):4345-9. PubMed ID: 12082624
[TBL] [Abstract][Full Text] [Related]
30. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
31. Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.
Galm O; Esteller M
Int J Hematol; 2004 Aug; 80(2):120-7. PubMed ID: 15481439
[TBL] [Abstract][Full Text] [Related]
32. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors.
Fraga MF; Herranz M; Espada J; Ballestar E; Paz MF; Ropero S; Erkek E; Bozdogan O; Peinado H; Niveleau A; Mao JH; Balmain A; Cano A; Esteller M
Cancer Res; 2004 Aug; 64(16):5527-34. PubMed ID: 15313885
[TBL] [Abstract][Full Text] [Related]
33. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
34. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis.
Casalino L; Verde P
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806509
[TBL] [Abstract][Full Text] [Related]
35. Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation.
Jacinto FV; Ballestar E; Esteller M
Oncogene; 2009 Nov; 28(47):4212-24. PubMed ID: 19734945
[TBL] [Abstract][Full Text] [Related]
36. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
[TBL] [Abstract][Full Text] [Related]
37. Promoter methylation status of multiple genes in uveal melanoma.
Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
[TBL] [Abstract][Full Text] [Related]
38. Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies.
Lio CJ; Yuita H; Rao A
Blood; 2019 Oct; 134(18):1487-1497. PubMed ID: 31467060
[TBL] [Abstract][Full Text] [Related]
39. Role of epigenetic changes in hematological malignancies.
Lehmann U; Brakensiek K; Kreipe H
Ann Hematol; 2004 Mar; 83(3):137-52. PubMed ID: 15064862
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
